TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05170997

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Cows' milk
Description: Intervention groups will receive a free 12 week supply of cows' milk equating to a pint a day for study participants. Milk is provided by Lakeland dairies.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Cows' milk
Description: Intervention groups will receive a free 12 week supply of cows' milk equating to a pint a day for study participants. Milk is provided by Lakeland dairies.
Study: NCT06145295

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: mobile online support group (experiment group)
Description: The experimental group engaged with the mobile application use for four weeks, with specific tasks including completing the four mandatory courses within one month and submitting at least two health records and online posts every week.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: offline support group (control group)
Description: The control group participates in the offline group intervention that last for four weeks. Participants in the control group will participant in four weekly workshop that last between 1 hour to 1.5 hours.
Study: NCT06434311

Intervention type: DIAGNOSTIC_TEST
Intervention: 3 meter Backward Test
Description: evaluation

Intervention type: DIAGNOSTIC_TEST
Intervention: 3 meter Backward Test
Description: evaluation
Study: NCT05170997

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: British Dietetic Association Iodine Fact Sheet.
Description: All participants will receive the British Dietetic Association Iodine fact sheet which discusses the importance of iodine and the dietary sources.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: British Dietetic Association Iodine Fact Sheet.
Description: All participants will receive the British Dietetic Association Iodine fact sheet which discusses the importance of iodine and the dietary sources.
Study: NCT05198271

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Management of risk factors
Description: * For all patients:~  * Online dietician consultation (45 min 1st consultation with set objectives then 15-20 min for the following ones) then proposal of varied weekly menus, adapted to different cultural and social contexts by email and reassessment at M3 and M6~ * Clinical and radiographic periodontological evaluation at M0 and M6 by a specialist with dental hygiene advice with delivery of equipment and scaling~ * Initial teleconsultation with motivational interview by sports doctor / APA (30 min) with evaluation of initial physical activity, search for contraindications and development of a personalized program with aerobic and resistance training. Provision of filmed sessions and digital exercise materials for regular practice at home and self-assessment using data from the accelerometer with automatic online report.~* Motivational supports on the MyGoodLife / MyGoodCare platform (weight, food questionnaire, pedometer, tobacco consumption)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Smoking cessation
Description: - For active smoking patients:~* Tobacco consultations: S0, S4 and S8 then according to the opinion of the tobacco specialist~* Nicotine substitutes +/- varenicline according to tobacco consumption~* Online notebook to record tobacco consumption and triggers

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: weightloss
Description: -For overweight or obese patients: Online dietician consultation every 15 days for 3 months, the consultation based on the online filling of food questionnaires and the weight curve
Study: NCT04484220

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ellipsys Vascular Access System
Description: The Ellipsys System is indicated for the creation of a proximal radial artery to perforating vein anastomosis via a retrograde venous access approach in patients with a minimum vessel diameter of 2.0mm and less than 1.5mm of separation between the artery and vein at the fistula creation site who have chronic kidney disease requiring dialysis.
Study: NCT04951635

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Almonertinib
Description: The initial dose of Almonertinib 110 mg daily can be reduced to 55 mg daily under specific conditions.~Treatment can continue until disease progression, unacceptable toxicity or other discontinuation criteria are met. The 2:1 ratio (Almonertinib to placebo).

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Almonertinib
Description: The initial dose of Placebo Almonertinib 110 mg daily can be reduced to 55 mg daily under specific conditions.~Treatment can continue until disease progression, unacceptable toxicity or other discontinuation criteria are met. The 2:1 ratio (Almonertinib to placebo).
Study: NCT06241391

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PSMA PET-CT
Description: Prostate Specific Membrane Antigen PET-CT
Study: NCT05023668

Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study: NCT05198271

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: periodontal disease treatment
Description: - For patients with periodontal disease: treatment of periodontal disease (planing, cast splint, tooth avulsion, etc.) between M0 and M3, dental panoramic M0 at inclusion and M6

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: increased physical activity
Description: - For patients with low physical activity: Follow-up by level gp session: 45 '/ week for 3 months

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Decreased anxiety
Description: - For anxious patients:~* Teleconsultation with a psychiatrist specializing in stress management, global assessment, identification of the factors involved and training in the use of cardiac coherence~* Delivery of connected equipment for the practice of cardiac coherence
Study: NCT06005961

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Module-Based Psychological (MBP) Intervention
Description: Participants will receive one core module related to emotional management and maximum two tailor-made modules according to the participant's needs. Each weekly session lasts for 1 hours. The core module will last for 6 weeks and the tailor-made modules will last for 3 - 4 weeks.

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Module-Based Psychological (MBP) Intervention
Description: Participants will receive one core module related to emotional management and maximum two tailor-made modules according to the participant's needs. Each weekly session lasts for 1 hours. The core module will last for 6 weeks and the tailor-made modules will last for 3 - 4 weeks.
Study: NCT02294799

Intervention type: OTHER
Group type: OTHER
Intervention: Intervention Group
Description: Grade 1, Nonspecific Mandibular Mobilization
Study: NCT06297746

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Subvastus approach
Description: Subvastus approach

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Medial Parapatellar approach
Description: Medial Parapatellar approach
Study: NCT05627596

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Ask-Advise-Refer
Description: All patients will be asked if they smoke, advised to quit, and referred to the state quitline
Study: NCT06090942

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Smartphone-based cognitive training
Description: Smartphone-based cognitive training
Study: NCT05627596

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Ask-Advise-Refer
Description: All patients will be asked if they smoke, advised to quit, and referred to the state quitline

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine Patch, 14 Mg/24 Hr Transdermal Film, Extended Release
Description: 14 mg transdermal nicotine patch
Study: NCT02294799

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo group
Description: Nonspecific Mandibular Movement.
Study: NCT05627596

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine lozenge
Description: 4mg nicotine lozenge
Study: NCT06118684

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EP395 (Part A and B)
Description: EP395 (test product) oral capsule 125 mg. Part A: Dose: 1 capsule as a single dose on Day 1 and Day 14, total daily dose: 125 mg.~Part B: Dose: 3 capsules once daily on Days 9 to 28, total daily dose: 375 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EP395 (Part A and B)
Description: EP395 (test product) oral capsule 125 mg. Part A: Dose: 1 capsule as a single dose on Day 1 and Day 14, total daily dose: 125 mg.~Part B: Dose: 3 capsules once daily on Days 9 to 28, total daily dose: 375 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Verapamil (Part A)
Description: Verapamil (CYP3A4/Pgp inhibitor), tablet 40 mg. Part A: Dose: 3 tablets twice daily Days 10 to 18, total daily dose: 240 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam (Part B)
Description: Midazolam (CYP3A4 substrate) oral solution 1 mg/mL. Part B: Dose: 4 mL as a single dose on Day 1 and Day 24, total daily dose: 4 mg.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Digoxin (Part B)
Description: Digoxin (Pgp substrate) tablet 0.25 mg. Part B: Dose: 1 tablet as a single dose on Day 1 and Day 24, total daily dose: 0.25 mg.
Study: NCT04956809

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin 10Mg Tab
Description: This will be a single-center randomized, placebo controlled, double-blind, 2-treatment, 2-phase cross-over trial in 27 HFrEF subjects: (A) Dapa 10 mg daily; (B) Placebo.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: This will be a single-center randomized, placebo controlled, double-blind, 2-treatment, 2-phase cross-over trial in 27 HFrEF subjects: (A) Dapa 10 mg daily; (B) Placebo.
Study: NCT06441916

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dabigatran Etexilate Capsules 150 mg
Description: Dabigatran Etexilate
Study: NCT04571203

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Combined Deceased Donor Kidney and Hematopoietic Cell Transplants
Description: This combined kidney and hematopoietic cell transplants with a conditioning regimen with irradiation and ATG creates an environment of immune-tolerance. This promotes hematopoietic cell engraftment.
Study: NCT06441916

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dabigatran Etexilate Capsules 150 mg
Description: Dabigatran Etexilate
Study: NCT05575323

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Same-day SBRT and spinal surgery
Description: SBRT and surgical stabilization with or without decompression within 24 hours

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard of care
Description: Surgical stabilization with or without decompression followed by cRT or SBRT as soon as the wound is healed sufficiently
Study: NCT06399887

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: All patients in these groups are taught diaphragmatic breathing, which is the basis for DNS, and are asked to maintain it throughout the exercises. The DNS protocol includes a 5-minute warm-up, 40 minutes of DNS exercises (10 minutes for each of the 4 different body parts) and breathing exercises. The DNS exercises included diaphragmatic breathing, Baby Rock, Roll Over, Lying on the Side, Sitting Down, Sitting Upright, Tripod, Kneeling, Squatting, Prone, and Pull Up (CGU). The focus of the first week is to teach and practice basic DNS exercises.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: All patients in these groups are taught diaphragmatic breathing, which is the basis for DNS, and are asked to maintain it throughout the exercises. The DNS protocol includes a 5-minute warm-up, 40 minutes of DNS exercises (10 minutes for each of the 4 different body parts) and breathing exercises. The DNS exercises included diaphragmatic breathing, Baby Rock, Roll Over, Lying on the Side, Sitting Down, Sitting Upright, Tripod, Kneeling, Squatting, Prone, and Pull Up (CGU). The focus of the first week is to teach and practice basic DNS exercises.
Study: NCT05623800

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PREM-Kit
Description: The PREM-Kit, which was created based on the Information-Motivation-Behavioral Skills model, is used in a series of HIV education sessions as part of the intervention. Over the course of three sessions, there will be a total of six weeks (one session for every two weeks). Three sub-modules, namely HIV facts and information, motivation for HIV preventive behavior, and behavioral skills for HIV prevention, will be emphasized in each session to the participants via flip chart and health educational videos. Additionally, participants will receive a QR code that gives them access to the PREM-Kit's e-flip chart, which they can see at a later time.
Study: NCT06399887

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Biofeedback
Description: Patients in Group II and Group III will be trained in animated CP using the Aymed Medical Locum Wireless System v.2.69.0.12 device. During CP, 10-second contraction and 30-second relaxation cycles are maintained throughout the animated game. Each session will last approximately 20 minutes. The training protocol will consist of a total of 12 sessions of 20 minutes per week for 3 months.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Biofeedback
Description: Patients in Group II and Group III will be trained in animated CP using the Aymed Medical Locum Wireless System v.2.69.0.12 device. During CP, 10-second contraction and 30-second relaxation cycles are maintained throughout the animated game. Each session will last approximately 20 minutes. The training protocol will consist of a total of 12 sessions of 20 minutes per week for 3 months.
Study: NCT06229795

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Green Tea Leaf Extract Decaffeinated
Description: 300 mg film coated tablet

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin Hydrochloride 500 MG
Description: 500 mg tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin Hydrochloride 500 MG
Description: 500 mg tablet
Study: NCT05433571

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test Lens
Description: Multifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test Lens
Description: Multifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test Lens
Description: Multifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test Lens
Description: Multifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test Lens
Description: Multifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test Lens
Description: Multifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test Lens
Description: Multifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test Lens
Description: Multifocal Toric Contact Lenses manufactured in Senofilcon A (C3) material with UV/HEV filter
Study: NCT04697875

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Normobaric hypoxia (FiO2 15%)
Description: Inhalation of deoxygenated air through an altitude simulator (Altitrainer), for approx. 1/2 hour given by a facemask, first at rest and then during exercise.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Placebo-ambient air (FiO2 21%)
Description: Inhalation of room air through an altitude simulator (Altitrainer), for approx. 1/2 hour given by a facemask, first at rest and then during exercise.
Study: NCT06247943

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lung Protective Ventilation Strategy
Description: After 10 minutes of pneumoperitoneum, VT 7 ml/kg was used, PEEP 6 cmH2O, FiO2 was 40%, and plateau pressure \<30 cmH2O was maintained throughout.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: regular ventilation
Description: VT 9ml /kg without PEEP, FiO2 of 60%
Study: NCT05455853

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental: bilateral transcutaneous tibial nerve stimulation,exercise and advices
Description: • First group they will receive morning bilateral transcutaneous tibial nerve stimulation, for 30 minutes, three times per week for 4 weeks, in addition to abdominal muscle training and breathing exercise for 15 minutes three times per week, for 4 weeks and bowel care advices.•They will perform abdominal muscle training and breathing exercise, for 15 minutes three times per week, for 4 weeks in addition to bowel care advices.~Second group•They will perform abdominal muscle training and breathing exercise, for 15 minutes three times per week, for 4 weeks in addition to bowel care advices.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental: bilateral transcutaneous tibial nerve stimulation,exercise and advices
Description: • First group they will receive morning bilateral transcutaneous tibial nerve stimulation, for 30 minutes, three times per week for 4 weeks, in addition to abdominal muscle training and breathing exercise for 15 minutes three times per week, for 4 weeks and bowel care advices.•They will perform abdominal muscle training and breathing exercise, for 15 minutes three times per week, for 4 weeks in addition to bowel care advices.~Second group•They will perform abdominal muscle training and breathing exercise, for 15 minutes three times per week, for 4 weeks in addition to bowel care advices.
Study: NCT05491356

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tissue Plasminogen Activator
Description: Dosage of 1mg/mL mixed in 0.9% saline solution, intra-catheter administration, sterile

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% saline solution, intra-catheter administration, sterile
Study: NCT06126302

Intervention type: OTHER
Intervention: Birth year
Description: we divided the patients according to patients' birth year

Intervention type: OTHER
Intervention: Birth year
Description: we divided the patients according to patients' birth year

Intervention type: OTHER
Intervention: Birth year
Description: we divided the patients according to patients' birth year

Intervention type: OTHER
Intervention: Birth year
Description: we divided the patients according to patients' birth year

Intervention type: OTHER
Intervention: Birth year
Description: we divided the patients according to patients' birth year

Intervention type: OTHER
Intervention: Birth year
Description: we divided the patients according to patients' birth year

Intervention type: OTHER
Intervention: Birth year
Description: we divided the patients according to patients' birth year

Intervention type: OTHER
Intervention: Birth year
Description: we divided the patients according to patients' birth year

Intervention type: OTHER
Intervention: Birth year
Description: we divided the patients according to patients' birth year

Intervention type: OTHER
Intervention: Birth year
Description: we divided the patients according to patients' birth year
Study: NCT05941195

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Description: In the cognitive behavioral approach based psychoeducation given to the experimental group patients; Addiction and Its Effects, Increasing and Maintaining Motivation, The Cognitive Model and the Cognitive Model of Addiction, Automatic Thoughts That Increase Impulse to Substance Use, Dysfunctional Beliefs Regarding Substance Use, High Risk Situations and Coping Skills,  The topics of Prevention of Slippage and Recurrence and Problem Solving are included.
Study: NCT05988476

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: 5 day/week, two week, one session stretching exercises consisting of ten repetitions of one minute

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: 5 day/week, two week, one session stretching exercises consisting of ten repetitions of one minute
Study: NCT06362057

Intervention type: OTHER
Intervention: Subperiosteal implant framework
Description: A 3D image of an edentulous maxilla bone will be derived from a computed tomography scan of an adult patient and saved as stl data. The solid geometry of the maxilla, including the cortical and spongious bone, was rebuilt from the stl data into the Digital Imaging and Communications in Medicine (DICOM) format with 3D-Doctor (Able Software Corp., MA, USA).~With the Boolean method, force loading will be achieved between prosthetic parts, subperiosteal implant screws and bone tissues

Intervention type: OTHER
Intervention: Subperiosteal implant framework
Description: A 3D image of an edentulous maxilla bone will be derived from a computed tomography scan of an adult patient and saved as stl data. The solid geometry of the maxilla, including the cortical and spongious bone, was rebuilt from the stl data into the Digital Imaging and Communications in Medicine (DICOM) format with 3D-Doctor (Able Software Corp., MA, USA).~With the Boolean method, force loading will be achieved between prosthetic parts, subperiosteal implant screws and bone tissues

Intervention type: OTHER
Intervention: Subperiosteal implant framework
Description: A 3D image of an edentulous maxilla bone will be derived from a computed tomography scan of an adult patient and saved as stl data. The solid geometry of the maxilla, including the cortical and spongious bone, was rebuilt from the stl data into the Digital Imaging and Communications in Medicine (DICOM) format with 3D-Doctor (Able Software Corp., MA, USA).~With the Boolean method, force loading will be achieved between prosthetic parts, subperiosteal implant screws and bone tissues
Study: NCT05988476

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulsed Electromagnetic Field Therapy
Description: 5 day/week, two week,two sessions consisting of 180 minutes

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulsed Electromagnetic Field Therapy
Description: 5 day/week, two week,two sessions consisting of 180 minutes
Study: NCT06363942

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: SAFE program (exercise intervention)
Description: Participants will be asked to carry out the SAFE program with the help of a caregiver. Our healthcare professionals will visit them during the first week to explain to them and their caregivers how to perform the exercises correctly while using our website. All exercises will be performed using video capsules available on our website (https://safe-seniors.com/fr). The exercises are divided into 4 levels of difficulty: level 1 (light); level 2 (moderate); level 3 (moderate to vigorous); and level 4 (vigorous). Each level lasts 25 to 30 minutes and includes 5 exercise categories split into 5 videos: warm-up, strength, balance, flexibility, and endurance. The exercise intervention will include 3 sessions per week over 12 weeks.